Dr. Frédéric Fellouse, researcher affiliated with Dr. Sachdev Sidhu’s laboratory at the University of Toronto, has a pharmacy and bioengineering background. His PhD work conducted at Genentech and the University of Provence, allowed the development of highly functional synthetic antibody repertoires surpassing the functionality of the natural immune system. This new generation of biologics enables quick and low-cost discovery of high performance reagents, therapeutics and diagnostics. As a postdoctoral fellow at the Lunenfeld Research Institute in Professor Wrana and Pawson, Dr. Fellouse developed synthetic antibodies as reagents to explore cell signalling. Dr. Fellouse now leads a protein engineering research program as well as the development of therapeutic and diagnostic antibodies to treat cancer, eye diseases and infectious diseases. In the area of infectious diseases, Dr. Fellouse’s current interests are around Dengue fever treatments and diagnostics and the improvement of a vaccine for cattle East Coast fever.